ArticleSAGE open medical case reports2025
Utility and outcome of piezoelectric bone conduction implant in managing mixed hearing loss with incomplete partition type 2 and enlarged vestibular aqueduct.
Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stapedial fixation coupled with incomplete partition type 2 and enlarged vestibular aqueduct (EVAS) represents a unique challenge in managing hearing loss owing to the risks of stapedial surgery and the need for alternative hearing restoration methods. This case report describes the selection, implementation, and outcomes of an Osia-2 implantable bone conduction device in a 17-year-old male patient with severe bilateral mixed hearing loss. Seventeen-year-old male patient with severe to profound bilateral mixed hearing loss due to incomplete partition type 2 and EVAS in the presence of audiolotical findings of stapedial fixation. His bone thresholds pure tone average of 40 dB hearing level and an air thresholds PTA of 70 dB hearing level. A nonsurgical bone conduction hearing assistive device demonstrated improved sound performance and high patient satisfaction. Subsequently, an OSI200 implant was used. A posteroinferior incision was created with the BI300 carefully placed 6.5 cm from the external auditory canal. The postoperative outcomes were remarkable, suggesting air-bone gap over-closure with an Osia-aided PTA of 31.67 dB hearing level and an aided speech discrimination score of 96%. Notably, the unaided bone conduction hearing remained unchanged, underscoring the efficacy of the implant in enhancing auditory function without compromising residual hearing. The patient maintained stable hearing levels up to 18 months, confirming the durability of hearing preservation and gain. This case underscores the efficacy of the OSI200 device in managing severe mixed hearing loss in patients with inner ear anomalies, such as incomplete partition type 2 and EVAS. The smooth soft drilling needed for the BI300 implant, and posterior placement, thus improving hearing without altering the unaided bone conduction thresholds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.